Leadership
The Respiragene™ test combines market leading assay development and test processing expertise in the United States with global leadership in scientific discovery and clinical study of lung cancer susceptibility.
Molecular Diagnostics Laboratories LLC
The Respiragene™ test has been specifically developed and validated for sale in the United States by Molecular Diagnostics Laboratories, LLC ("MDL"), a personalized medicine specialist group based in Covington, Kentucky. MDL operates a state of the art CLIA-compliant laboratory testing facility and offers a growing range of proprietary genetic-based tests for cardiovascular diagnostic and pharmacogenomic applications. MDL is the clinical lab division of PhD Diagnostics, and part of the larger BioLOGIC LLC network, established as an accelerator for innovative products and services in the diagnostic, therapeutic and medical instrumentation sectors. Please see www.mdl-labs.com for greater detail on the laboratory, its capabilities and the facility's regulatory status.
Dr. Robert P. Young, Synergenz Chief Scientific Officer
Dr. Robert Young is a practicing clinician with extensive hospital experience in the United Kingdom, Hong Kong and New Zealand. He has treated thousands of patients with Lung Cancer and Chronic Obstructive Pulmonary Disease (COPD) developed as a result of their smoking habits. In addition, he is highly trained in molecular genetics and has undertaken numerous genetic epidemiological studies over the last sixteen years, several of which have contributed to the core discoveries underpinning the Respiragene™ test.
After earning a medical degree at New Zealand's Otago University, Dr. Young completed his Ph.D. at the University of Oxford (UK) for his research on the genetics of asthma, and subsequently trained in internal medicine in London and Hong Kong. He has published four book chapters, two theses and sixty-five peer-reviewed publications or abstracts, and is a Fellow of the Hong Kong College of Physicians, the Royal Australasian College of Physicians and the Royal College of Physicians (UK). Dr Young is a founding director of Synergenz and leads of a team of scientists and clinicians based at the University of Auckland (New Zealand) conducting ongoing research into genetic susceptibility to pulmonary disease.





















